FESOTERODINE FUMARATE
Generic: FESOTERODINE FUMARATE
Camber PharmaceuticalsManufacturer
ORALRoute
FESOTERODINE FUMARATEActive Substance
2024-01-09Original Approval
FESOTERODINE FUMARATE is FDA application ANDA204792, sponsored by HETERO LABS LTD V. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Recalls
Class III2025-12-16
Fesoterodine Fumarate, Extended-release Tablets, 8 mg, 30 Tablets, Rx only, Manufactured by: Alembic Pharmaceuticals LimFailed Impurities/Degradation Specifications: Due to levels of 'Diester Impurity' exceeding the spec
Class III2025-10-10
Fesoterodine Fumarate, Extended-release Tablets, 4 mg, 30-count bottle, Rx only, Manufactured by: Alembic PharmaceuticalFailed Impurities/Degradation Specifications: Due to levels of 'Diester Impurity' exceeding the spec
Top Reported Reactions
1
DRUG INEFFECTIVE
165 reports
2
OFF LABEL USE
157 reports
3
PAIN
157 reports
4
CEREBROVASCULAR ACCIDENT
155 reports
5
VERTIGO
155 reports
6
ABDOMINAL DISCOMFORT
153 reports
7
CONFUSIONAL STATE
151 reports
8
FATIGUE
151 reports
9
WEIGHT DECREASED
151 reports
10
COVID-19
150 reports